Potassium channel openers: pharmacological and clinical aspects.
about
A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids.Pharmacological evidence for the activation of potassium channels as the mechanism involved in the hypotensive and vasorelaxant effect of dioclein in rat small resistance arteriesPolyunsaturated fatty acids are potent neuroprotectorsEssential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning.Regional and species differences in glyburide-sensitive K+ channels in airway smooth muscles as estimated from actions of KC 128 and levcromakalim.Effects of cromakalim on the electrical slow wave in the circular muscle of guinea-pig gastric antrum.K+ channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein, and amyloid beta-protein precursor genes and neuronal death in rat hippocampus.Influence of Thromboxane A2 on the Regulation of Adenosine Triphosphate-Sensitive Potassium Channels in Mouse Ventricular Myocytes.Molecular expression and functional role of canonical transient receptor potential channels in airway smooth muscle cellsPinacidil and levamisole prevent glutamate-induced death of hippocampal neuronal cells through reducing ROS production.Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.Intracellular nucleotide-mediated gating of SUR/Kir6.0 complex potassium channels expressed in a mammalian cell line and its modification by pinacidil.K+ channel opening: a new drug principle in cardiovascular medicine.Contribution of Na+ -Ca2+ exchanger to pinacidil-induced relaxation in the rat mesenteric artery.The effect of L-type calcium channel modulators on the mobilization of intracellular calcium stores in guinea-pig intestinal smooth muscle.Comparison of the effects of nicorandil, pinacidil and nitroglycerin on hypoxic and hypercapnic pulmonary vasoconstriction in the isolated perfused lung of rat.Effects of pinacidil on arterial and venous resistances and mean circulatory filling pressure in rats.Effect of KC399, a newly synthesized K+ channel opener, on acetylcholine-induced electrical and mechanical activities in rabbit tracheal smooth muscle.Interaction between ATP-sensitive K+ channels and nitric oxide on pial arterioles in piglets.Topical Minoxidil Versus Topical Diltiazem for Chemical Sphincterotomy of Chronic Anal Fissure: A Prospective, Randomized, Double-Blind, Clinical Trial.Anticonvulsant effect of Diazoxide against Dichlorvos-induced seizures in mice.
P2860
Q24533254-B89C30B5-76A2-4316-9592-47B692A3C050Q28343916-7969188E-E639-4E80-94C0-729D93B906B2Q28344163-D927BB9C-63A9-47C8-B590-DE1CC1F3D692Q34357041-381D5581-62C4-4C62-AA57-A25562778C8FQ34793478-E2433CF1-4F64-4F43-B9E2-A47A52D3B4ECQ36329785-231BFF97-69DD-4AD9-B6D9-256680B8D1EDQ36592326-263A38AC-FF72-4225-90BB-5B4239E9CF7EQ37136553-D73290F2-F984-4AE5-9034-6C8005CD0CCDQ37835162-A7124A9D-DA49-4832-9D78-7B0C21BA2413Q38852038-FE1943F7-3FDF-4E73-934F-1CDB8C2ED636Q39195631-383BB2B4-E548-441B-B349-190634548DE0Q41014158-E6F67976-F739-4F26-B5FE-FFEE3BDD737DQ41104214-85E0975A-9FF3-440A-87EA-6FCE21AC10B7Q41926140-BA315EFD-13A6-4EEC-ADAB-06DE296B60D8Q41958618-5C55DF05-7431-45E0-970F-B0D41FA849ACQ42705970-BFCC192D-44FD-4CB0-AF5E-193CCB526A31Q42708253-20E76FD3-7D15-47B7-A9A1-2D17B16204A5Q42709016-B2554355-44AC-4F6D-934B-BD93C941565EQ48882792-5BF72B40-3CE9-49B4-BA84-69304E653494Q49382561-E58DED91-0F7F-49FC-87CF-A45B16EB6144Q52765302-C9457B50-4712-4B71-B06A-690619F76BD3
P2860
Potassium channel openers: pharmacological and clinical aspects.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Potassium channel openers: pharmacological and clinical aspects.
@ast
Potassium channel openers: pharmacological and clinical aspects.
@en
type
label
Potassium channel openers: pharmacological and clinical aspects.
@ast
Potassium channel openers: pharmacological and clinical aspects.
@en
prefLabel
Potassium channel openers: pharmacological and clinical aspects.
@ast
Potassium channel openers: pharmacological and clinical aspects.
@en
P2860
P1476
Potassium channel openers: pharmacological and clinical aspects.
@en
P2093
P2860
P304
P356
10.1111/J.1472-8206.1992.TB00122.X
P577
1992-01-01T00:00:00Z